跨专业重症监护中的药剂师:优化药物管理
Jeffrey F Barletta1, Amy L Dzierba2
1College of Pharmacy, Midwestern University, Glendale, AZ, USA.
Critical care clinics
|March 13, 2026
概括
优化危急病患者的药物剂量是一项挑战. 临床护理药剂师在管理药物方面发挥着至关重要的作用,确保重症监护室 (ICU) 患者的安全和有效药物治疗.
科学领域:
- 药理学 药理学是指药理学的学科.
- 关键护理医学 关键护理医学
- 临床药房 临床药房
背景情况:
- 由于生理变化和医疗干预,重症患者的药物剂量是复杂的.
- 不足够或过量的剂量可能导致治疗失败或不良事件.
- 重症监护药剂师是重症监护病房 (ICU) 团队的重要成员.
研究的目的:
- 为了突出优化药物剂量对重症患者的挑战.
- 强调重症监护药剂师在药物治疗管理中的独特作用和责任.
- 强调药剂师在保证ICU中药物安全和有效性的重要性.
主要方法:
- 在危急疾病中对药理动力学和药理动力学原理的审查.
- 分析疾病状态和体外器械对药物处置的影响.
- 检查重症监护药剂师对药物管理的贡献.
- 讨论药剂师的职责,包括教育,准则制定和监督.
主要成果:
- 重症患者的动态生理变化显著改变药物的药理动力学和药理动力学.
- 像体外器械这样的干预措施进一步复杂化了药物剂量策略.
- 临床护理药剂师在药物管理,安全性和有效性方面提供必要的专业知识.
- 药剂师积极为教育,指导方针的实施和与药物相关的问题解决做出贡献.
结论:
- 在重症患者中有效的药物剂量需要专业知识和主动管理.
- 临床护理药剂师在优化ICU中的药物治疗方面处于独特的地位.
- 药剂师的多方面的作用对于改善患者的治疗结果和确保药物安全至关重要.
相关概念视频
01:26Pharmaceutical Poisoning: Potential Scenarios
53
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
53
01:27Coronary Artery Disease V: Interprofessional Care
359
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
359
01:28Acute Coronary Syndrome IV: Interprofessional Care
376
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
376
01:15Drug Dosing: Geriatric Patients
339
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
339
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
349
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
349
01:24Pharmacokinetic–Pharmacodynamic Relationship: Problems
62
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
62